Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Mar 18, 2011

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – GenMark Diagnostics has tapped Paul Ross to serve as chief financial officer, a position he will assume in April. Ross currently is CFO at Teledata, and he formerly held the same position at Meade Instruments and at Power-One.

Cepheid has nominated Glenn Steele to be elected to its board of directors at its annual shareholders meeting in April. Steele has been president and CEO of Geisinger Health System since 2001, and before that he was a professor, VP for medical affairs, and dean of the biological sciences division and the Pritzker School of Medicine at the University of Chicago. Steele also previously was a professor at Harvard Medical School and president and CEO of Deaconness Professional Practice Group and chairman of the Department of Surgery at New England Deaconess Hospital.

Seattle Biomedical Research Institute (Seattle BioMed) has hired Alan Aderem, co-founder and a former director of the Institute for Systems Biology, to be its new director — and it will hire more than 40 ISB researchers and staff as part of an expansion plan. Under Seattle BioMed's plan, Aderem will replace its current President and Founder Ken Stuart at the beginning of 2012. Stuart will remain with Seattle BioMed as founder and president emeritus and he will maintain his own research program with the institute. Both Aderem and Stuart will continue their work as professors at the University of Washington.

Exact Sciences has named John Krayacich to be senior VP of sales and marketing. Krayacich recently was president and CEO of Ambrose Pharmaceuticals and Marinus Pharmaceuticals, where he worked in strategic and marketing planning and business development and financial management. He also was VP and therapeutic area head at Novartis Pharmaceutical and VP and therapeutic group leader at Pfizer Neurosciences.

IncellDx has named Keith Shults to be director of its research and development team, where he will be responsible for development of a new version of the HPV OncoTect product. Shults was the co-founder of Cytometry Associates, and he later was VP of technology transfer in the Center for Innovation at Esoterix and director of advanced cytometric applications at Nodality.

Flourotechnics of Sydney, Australia said this week that James Walker plans to retire from his spot as executive director to continue his work in an outside job. The company also said that due to a planned strategic acquisition at the company, it has made other changes at the board of directors, including naming Richard Trevillion chairman and managing director, and Rick Taylor and Damian Pethica as executive directors.

Rick Rylance, a professor and chief executive of the Arts and Humanities Research Council, has been appointed the new chair of Research Councils UK (RUCK), which is the partnership between all seven of the UK's Research Councils.

Rylance, who will serve in that role until 2013, will replace outgoing chair Professor Alan Thorpe, who also is CEO of the Natural Environment Research Council.

Patrick Jones has been named to serve on Fluidigm's board of directors, where he will replace Jeremy Loh. Jones previously was senior VP and CFO of Gemplus International, and he was VP and corporate controller at Intel Corp.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.